PATTIE HERBST: Open Payments
NPI 1760191951 · ARLINGTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$711 in 34 payments from 10 companies in 2025. Trend: 2023 $174 · 2024 $746 · 2025 $711
Food & beverage: $711
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 7 | $173 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $149 |
| Bausch Health US, LLC | 5 | $95 |
| Otsuka America Pharmaceutical, Inc. | 4 | $87 |
| ABBVIE INC. | 2 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Corium, LLC | 2 | $33 |
| Axsome Therapeutics, Inc. | 1 | $32 |
| Janssen Pharmaceuticals, Inc | 1 | $28 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
Products named: REXULTI, CAPLYTA, APLENZIN, VRAYLAR, TRINTELLIX, Azstarys, Auvelity, SPRAVATO.
Industry payments across VA — which companies pay providers there.
